UTMD vs UFPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UTMD Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Utah Medical Products Inc (UTMD) driven by superior Valuation, Growth & Margin, Momentum & Technical while UFPT counters with relative strength in Options & Structure. Fundamentally, UTMD trades at 13.0x Forward P/E with 34.3% operating margin (-12.1% YoY revenue) versus UFPT at 24.7x Forward P/E and 15.4% operating margin (+11.6% YoY). In options structure, UTMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UTMD | UFPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $204.9M | $2.4B | Larger Scale | UFPT |
| Trailing P/E Ratio Valuation | 21.6x | 31.2x | Lower Multiple | UTMD |
| Forward P/E Ratio Valuation | 13.0x | 24.7x | Lower Multiple | UTMD |
| Revenue Growth (YoY) Growth | -12.1% | +11.6% | Higher Growth | UFPT |
| Operating Margin (TTM) Profitability | 34.3% | 15.4% | Higher Margin | UTMD |
| Net Profit Margin Profitability | 30.5% | 11.8% | Higher Margin | UTMD |
| Return on Equity (ROE) Capital Efficiency | 8.8% | 17.2% | Higher ROE | UFPT |
| 52-Week Range Position Momentum | 80% ($54โ$77) | 74% ($174โ$342) | Stronger Trend | UTMD |
| Beta / 30D Volatility Risk Regime | 0.23ฮฒ ยท 33% Vol | 1.64ฮฒ ยท 77% Vol | Lower Realized Risk | UTMD |
| Unified Institutional Score Composite Signal | 52.9 / 100 (HOLD) | 42.6 / 100 (HOLD) | Higher Composite | UTMD |